CAS: 13058-04-3 - farnesyl pyrophosphate ammonium*200 ug/vial
Fórmula:C15H28O7P2
InChI:InChI=1S/C15H28O7P2/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-21-24(19,20)22-23(16,17)18/h7,9,11H,5-6,8,10,12H2,1-4H3,(H,19,20)(H2,16,17,18)
Clave InChI:InChIKey=VWFJDQUYCIWHTN-UHFFFAOYSA-N
SMILES:O=P(O)(O)OP(=O)(O)OCC=C(C)CCC=C(C)CCC=C(C)C
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Diphosphoric acid, P-(3,7,11-trimethyl-2,6,10-dodecatrien-1-yl) ester REF: IN-DA000UO7CAS: 13058-04-3 | - - - | A consultar | Mar 12 Nov 24 |
 | Farnesyl pyrophosphate REF: TM-T73755CAS: 13058-04-3 | - - - | A consultar | Mié 13 Nov 24 |
Diphosphoric acid, P-(3,7,11-trimethyl-2,6,10-dodecatrien-1-yl) ester
CAS:13058-04-3
Fórmula:
C15H28O7P2
Peso molecular:
382.3261
Ref: IN-DA000UO7
| 1mg | A consultar | ||
| 5mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 12 de Noviembre de 2024
Farnesyl pyrophosphate
CAS:13058-04-3
Farnesyl pyrophosphate: 15-C isoprenoid, TRPM2 agonist, crucial for cholesterol, ubiquinones, protein farnesylation, and GGPP synthesis.
Fórmula:
C15H28O7P2
Forma y color:
Solid
Peso molecular:
382.33
Ref: TM-T73755
| 5mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 13 de Noviembre de 2024
